T1	intervention 18 37	omega-3 fatty acids
T2	intervention 42 52	Raloxifene
T3	eligibility 493 549	Postmenopausal women at increased risk for breast cancer
T4	control 597 612	no intervention
T5	duration 700 707	2 years
T6	outcome-Measure 709 736	Reduction in breast density
T7	No-of-participants 971 973	46
T8	outcome 1015 1052	All interventions were well tolerated
T9	outcome 1280 1299	serum triglycerides
T10	outcome 1314 1356	high-density lipoprotein (HDL) cholesterol
T11	outcome 1410 1421	serum IGF-1
T12	outcome 1504 1520	IGF-1 or IGFBP-3
